Health & Biotech
MMJ Group (ASX: MMJ) has changed its name to Hygrovest - HGV (ASX: HGV).
Below are the previous articles from MMJ Group (ASX: MMJ):
RELATED STOCKHEAD STORIES
Health & Biotech
Weed Week: The CanCoin, cannabis tourism, and record medicinal product sales in Australia
Stockhead TV
V-Con: Medical cannabis – green grass, green growth
Health & Biotech
The ASX pot stocks looking to get high on Canada’s $3bn market
News
North American pot stocks are on fire, Aussies still MIA
Health & Biotech
MMJ doubles down on EU cannabis extractor with big investment
Health & Biotech
Weed Week: Asking the big questions – what takes priority in a pandemic, cannabis or toilet paper?
Health & Biotech
Will 2021 be the recovery year for cannabis?
Health & Biotech
North Americans are stockpiling cannabis for COVID crackdowns and this could finally fix the market
Health & Biotech
MMJ Holdings stays flexible on capital strategy, offers improved terms to investors
Food & Agriculture
Health Kick Podcast: The strategy and upside behind global cannabis investment company MMJ
Health & Biotech
The outlook is sunny for Harvest One Cannabis and its biggest investor, MMJ Group
Health & Biotech
Ace in the hole: MMJ Group’s direct exposure to the huge North American cannabis market is poised to pay dividends
Health & Biotech
Biotech big guns are buying up the minnows
Health & Biotech
Cannabis: MMJ drops $2.2m on North American Harvest One
Health & Biotech
Weed Week: Wait till cannabis is legalised federally in the US – big pharma are already dreading it
Health & Biotech
Cannabis: THC just got those long-awaited narcotics licenses
Health & Biotech
